All the symptoms and pathology of malaria are caused by the intraerythrocytic stages of the Plasmodium parasite life cycle. Because Plasmodium parasites cannot replicate outside a …
Antigenic diversity has posed a critical barrier to vaccine development against the pathogenic blood-stage infection of the human malaria parasite Plasmodium falciparum. To …
Numerous efforts to understand the functional roles of antibodies demonstrated that they can protect against malaria. However, it is unclear which antibody responses are the best …
Plasmodium parasites are the causative agent of human malaria, and the development of a highly effective vaccine against infection, disease and transmission remains a key priority. It …
TM Tran, A Ongoiba, J Coursen… - The Journal of …, 2014 - academic.oup.com
Background. Plasmodium falciparum reticulocyte-binding protein homologue 5 (PfRH5) is a blood-stage parasite protein essential for host erythrocyte invasion. PfRH5-specific …
Despite ongoing efforts, a highly effective vaccine against Plasmodium falciparum remains elusive. Vaccines targeting the pre-erythrocytic stages of the P. falciparum life cycle are the …
K Miura - Expert review of vaccines, 2016 - Taylor & Francis
There have been significant decreases in malaria mortality and morbidity in the last 10-15 years, and the most advanced pre-erythrocytic malaria vaccine, RTS, S, received a positive …
AS Paul, ES Egan, MT Duraisingh - Current opinion in hematology, 2015 - journals.lww.com
Host–parasite interactions that guide red blood cell invasio... : Current Opinion in Hematology Host–parasite interactions that guide red blood cell invasion by malaria …
GE Weiss, BS Crabb, PR Gilson - Trends in parasitology, 2016 - cell.com
A highly-effective, long-lasting vaccine, targeting multiple stages of the Plasmodium falciparum life cycle, is likely to be important for the elimination of this pathogen. Key …